Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,289 | 1,177 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,905 | 148 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,668 | 87 | $0 (2023) |
| Novo Nordisk Inc | $1,568 | 137 | $0 (2023) |
| Lilly USA, LLC | $1,300 | 125 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,122 | 77 | $0 (2023) |
| AbbVie Inc. | $1,065 | 87 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $1,019 | 70 | $0 (2022) |
| Allergan, Inc. | $687.61 | 76 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $592.49 | 62 | $0 (2023) |
| Gilead Sciences, Inc. | $463.24 | 37 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.95 | 1 | Abbott Laboratories ($20.95) |
| 2023 | $1,870 | 117 | GlaxoSmithKline, LLC. ($337.96) |
| 2022 | $1,825 | 113 | GlaxoSmithKline, LLC. ($278.12) |
| 2021 | $2,123 | 139 | Novo Nordisk Inc ($370.01) |
| 2020 | $2,219 | 149 | GlaxoSmithKline, LLC. ($313.11) |
| 2019 | $2,839 | 251 | Lilly USA, LLC ($356.13) |
| 2018 | $2,300 | 204 | AstraZeneca Pharmaceuticals LP ($392.59) |
| 2017 | $2,092 | 203 | AstraZeneca Pharmaceuticals LP ($325.88) |
All Payment Transactions
1,177 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Vascular | ||||||
| 09/28/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Neuromodulation | ||||||
| 09/28/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Neuromodulation | ||||||
| 09/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardio-renal | ||||||
| 09/26/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 09/14/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: PAIN | ||||||
| 09/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Neuroscience | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Oncology | ||||||
| 09/06/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: PAIN | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: RESPIRATORY | ||||||
| 09/01/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: RESPIRATORY | ||||||
| 08/24/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: INSOMNIA | ||||||
| 08/24/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.06 | General |
| 08/22/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.49 | General |
| Category: NEUROLOGY | ||||||
| 08/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: PSYCHIATRY | ||||||
| 08/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 801 | 868 | $75,393 | $42,245 |
| 2022 | 11 | 810 | 875 | $61,231 | $43,848 |
| 2021 | 11 | 609 | 689 | $50,353 | $34,334 |
| 2020 | 7 | 438 | 517 | $36,521 | $22,058 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 108 | 108 | $19,680 | $14,199 | 72.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 213 | $24,713 | $11,704 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 112 | $18,494 | $8,687 | 47.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 70 | 73 | $5,746 | $2,399 | 41.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 88 | 88 | $1,721 | $1,682 | 97.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 81 | 81 | $1,572 | $1,548 | 98.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 27 | 27 | $697.86 | $695.97 | 99.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 18 | 19 | $1,161 | $655.86 | 56.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 23 | $757.00 | $373.06 | 49.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 109 | 111 | $666.50 | $242.36 | 36.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 13 | $184.63 | $59.78 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 113 | 113 | $14,850 | $14,634 | 98.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 190 | 225 | $19,168 | $11,514 | 60.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 127 | $14,848 | $8,769 | 59.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 76 | 79 | $3,944 | $2,100 | 53.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $1,937 | $1,853 | 95.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 88 | 88 | $1,835 | $1,695 | 92.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 75 | 75 | $1,548 | $1,418 | 91.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 33 | 33 | $952.86 | $860.17 | 90.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 17 | 17 | $1,116 | $737.01 | 66.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 85 | 91 | $805.50 | $200.28 | 24.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 15 | 16 | $227.00 | $67.94 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 81 | 81 | $10,493 | $10,493 | 100.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 147 | $16,463 | $9,560 | 58.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 128 | 156 | $12,037 | $7,175 | 59.6% |
About Dr. Donovan Runyan, MD
Dr. Donovan Runyan, MD is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699752774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donovan Runyan, MD has received a total of $15,289 in payments from pharmaceutical and medical device companies, with $20.95 received in 2024. These payments were reported across 1,177 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($15,289).
As a Medicare-enrolled provider, Runyan has provided services to 2,658 Medicare beneficiaries, totaling 2,949 services with total Medicare billing of $142,485. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 12/29/2005
- Last Updated 09/07/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1699752774
Products in Payments
- JARDIANCE (Drug) $1,097
- FARXIGA (Drug) $794.22
- TRELEGY ELLIPTA (Drug) $786.99
- Ozempic (Drug) $622.13
- TRULICITY (Drug) $479.75
- VRAYLAR (Drug) $478.84
- LINZESS (Drug) $418.19
- SHINGRIX (Biological) $399.25
- UBRELVY (Drug) $356.99
- SOLIQUA 100/33 (Biological) $338.23
- TOUJEO (Drug) $317.43
- ANORO (Drug) $314.57
- SYMBICORT (Drug) $280.74
- TRINTELLIX (Drug) $277.90
- Trintellix (Drug) $270.16
- NURTEC ODT (Drug) $258.38
- XIFAXAN (Drug) $245.69
- Victoza (Drug) $233.74
- Livalo (Drug) $229.71
- EMGALITY (Drug) $206.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768